Home
University of Bergen
Department of Clinical Medicine

News archive for Department of Clinical Medicine

A teacher on the podium in front of a class of students.
To the Point—Scientific Writing and Communication Seminar with Christine Møller (19.06.2025)
Getting started on a manuscript or scientific text can often feel like the hardest part. Wouldn't it be great to have expert guidance to kickstart the process? That’s exactly what seventy-five students and several researchers signed up for when they filled the auditorium for this year’s CCBIO908 Scientific Writing & Communication Seminar, held May 20–21, 2025.
Collage with 3 photos: Dana in warn clothes, holding the CCBIO cup. Group photo of the doctors, smiling at the camera. Outside in the courtyard with one person giving information to the local residents.
From Bergen to the Himalayas: The CCBIO Cup Joins a Medical Mission to Nepal (16.06.2025)
This April, the CCBIO cup traveled far beyond its usual surroundings—all the way to the Himalayas, accompanying CCBIO Principal Investigator Professor Daniela Elena Costea from the University of Bergen (UiB) on a remarkable health charity mission. The destination: Manang, a remote village located at 3,540 meters in the mountains of Nepal.
Two researchers in lab coats and face masks working in a lab, looking in a microscope and discussing. One of them is Harsh Dongre.
FRIPRO funding for a new frontier in cancer immunoediting (13.06.2025)
On June 10, 2025, the Research Council of Norway announced funding for new projects in the FRIPRO scheme. Of the 3 awarded projects to the UiB, CCBIO Postdoc Harsh Dongre in Dana Costea's group received 3-year project support with international mobility.
The Nobel Symposium poster, text anout the event, on a black background with a blue artistic illustration of a brain.
Nobel Symposium on Multiple Sclerosis Highlights EBV Link (03.06.2025)
For the first time, a Nobel Symposium has been dedicated to Multiple Sclerosis (MS), bringing global experts to Stockholm on June 2–5, 2025. Hosted at the Karolinska Institutet, the symposium - “Multiple Sclerosis: From Molecular Mechanisms to Disease-Modifying Treatments” - features leading researchers from Europe and the U.S., including several key members of the EBV-MS consortium.
Picture of an open laptop with a digital meeting in progress, a person talking to the camera.
Advancing Clinical Research on EBV in MS (27.05.2025)
Highlights from the Mystery Solved Project 2025
(From left to right): Professor Øivind Torkildsen [credit: Eivind Senneset], Silje Tufta [credit Silje Tufta], and Dr. Sam Anandhan [credit: Spiros Kotopoulis]
New EBV-MS Video Highlights Groundbreaking Research and Human Stories Behind the Science (21.05.2025)
A new video from the EBV-MS research project is set to shed light on the role of the Epstein-Barr virus (EBV) in multiple sclerosis (MS), offering a glimpse into the pioneering research efforts and the personal experiences of those involved. The EBV-MS project, funded by Horizon Europe and led by the University of Bergen, aims to unravel why only some people infected with EBV go on to develop MS... Read more
David Lane on stage, talking with eager arm movements.
CCBIO crossroads at Solstrand (16.05.2025)
The 13th CCBIO Annual Symposium at Solstrand marks a shift in the strategy of the center, towards more focus on innovation and industry development.
Ass. Prof. Øystein Eikrem receives the prize of best research environment in 2024 at the Faculty of Medicine
Winners of 2024 Best Research Environment Prize at the Faculty of Medicine (29.04.2025)
The Renal Research Group wins the prize of the best research environment in 2024
Program for Bergen Meeting of Nephrology
Bergen Meeting of Nephrology 2025 (29.04.2025)
The Renal Research Group is organizing Bergen Meeting of Nephrology on May 8th 2025 at Haukeland University Hospital (B-302)
Newsletter April 2025 (22.04.2025)
Alberto Ascherio
UiB Honorary Doctor receives the annual "Breakthrough Prize" (08.04.2025)
Honorary Doctor at UiB, Alberto Ascherio, receives the prize for his groundbreaking research on MS.
Ghazal standing in front of Harvard Medical School in her winter clothes, with snow on the ground and in the air.
Lab exchange at Boston Children’s Hospital, Harvard Medical School (17.03.2025)
Over two months in October–December 2024, PhD Candidate Ghazal Lessan Toussi in Carina Strell’s group at CCBIO was given the opportunity to be on a research lab stay in Dr. Watnick’s laboratory at Boston Children's Hospital in Boston, USA. This was organized in the CCBIO–VBP Lab Visit Program, which is part of the CCBIO INTPART collaboration. Ghazal returned with lots of new knowledge and... Read more
Photo of a whiteboard full of research subjects to be considered, written by Jidah Folkman in 2007. Never erased.
One year abroad as building block on a career path (17.03.2025)
CCBIO Postdoc Harsh Dongre is currently in his 11th month in Boston on his research year abroad. Now that he soon will be returning, we have asked him to reflect a little bit about doing a year abroad as part of a career path, why he chose Boston, and what he has been doing there.
Newsletter December 2024 (08.01.2025)
Lars and Heidrun together in the lab.
What happens when tumors get nervous? (20.12.2024)
12 mill NOK was today (Dec. 20, 2024) awarded to Lars A. Akslen and Heidrun Vethe from the Research Council of Norway (FRIPRO) on the project "When breast cancer hits a nerve - neural involvement as a hallmark of tumor progression."
Two researchers in the Neuro-SysMed lab.
New project support to a range of Neuro-SysMed researchers (20.12.2024)
The Western Norway Regional Health Authorities (Helse Vest) has recently announced their project funding for 2025, and we are happy to see many Neuro-SysMed researchers in their announcement. In addition, other funding agencies have also granted support to our projects this fall.
Picture from the auditorium with many people in the audience, and the speaker being introduced on the stage.
Inspirational last CCBIO seminar of 2024 (19.12.2024)
CCBIO has a tradition of using the December meeting in its seminar series to add a different perspective and encourage our research environment to think outside of the box. This December, we had the pleasure of welcoming back Fran Balkwill, who has a unique experience in addition to her cancer research career.
Brekken as speaker on a CCBIO conference.
New biomarker identified for therapeutic intervention for reducing tumor progression (19.12.2024)
The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

Pages